NCT00998946 2021-11-05Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaSpectrum Pharmaceuticals, IncPhase 2 Completed29 enrolled 8 charts
NCT03349333 2019-10-01A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCLMundipharma (China) Pharmaceutical Co. LtdPhase 3 Completed85 enrolled 26 charts